RPS6KB2
Basic information
Region (hg38): 11:67428459-67435401
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RPS6KB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 37 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 1 | |||||
Total | 0 | 0 | 37 | 3 | 0 |
Variants in RPS6KB2
This is a list of pathogenic ClinVar variants found in the RPS6KB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-67428568-A-G | not specified | Uncertain significance (May 23, 2023) | ||
11-67429211-C-T | not specified | Uncertain significance (May 30, 2024) | ||
11-67429572-T-C | not specified | Uncertain significance (Jan 19, 2022) | ||
11-67431368-G-A | not specified | Uncertain significance (Nov 09, 2022) | ||
11-67431402-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
11-67431408-G-A | not specified | Uncertain significance (Jul 27, 2021) | ||
11-67431455-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
11-67431465-A-G | not specified | Uncertain significance (Apr 27, 2022) | ||
11-67431513-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
11-67432652-G-A | Likely benign (Nov 01, 2022) | |||
11-67432740-C-G | not specified | Uncertain significance (Nov 10, 2022) | ||
11-67432778-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
11-67432781-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
11-67432796-A-G | not specified | Uncertain significance (Mar 21, 2023) | ||
11-67432798-C-T | not specified | Uncertain significance (May 02, 2023) | ||
11-67432813-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
11-67433158-A-G | not specified | Uncertain significance (Jun 21, 2022) | ||
11-67433161-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
11-67433173-G-C | Uncertain significance (Jan 17, 2024) | |||
11-67433199-G-A | not specified | Uncertain significance (Dec 20, 2021) | ||
11-67433382-A-T | not specified | Uncertain significance (May 23, 2023) | ||
11-67433409-C-T | not specified | Uncertain significance (Nov 07, 2023) | ||
11-67433422-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
11-67433430-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
11-67433990-C-T | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RPS6KB2 | protein_coding | protein_coding | ENST00000312629 | 15 | 6942 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.96e-21 | 0.000431 | 124631 | 0 | 213 | 124844 | 0.000853 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.205 | 316 | 306 | 1.03 | 0.0000197 | 3090 |
Missense in Polyphen | 128 | 112.41 | 1.1387 | 1196 | ||
Synonymous | -1.67 | 147 | 123 | 1.19 | 0.00000777 | 981 |
Loss of Function | -0.618 | 29 | 25.6 | 1.13 | 0.00000127 | 287 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00110 | 0.00108 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00230 | 0.00228 |
Finnish | 0.0000466 | 0.0000464 |
European (Non-Finnish) | 0.000884 | 0.000874 |
Middle Eastern | 0.00230 | 0.00228 |
South Asian | 0.00128 | 0.00128 |
Other | 0.000330 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphorylates specifically ribosomal protein S6.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Fc gamma R-mediated phagocytosis - Homo sapiens (human);TGF-beta signaling pathway - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Insulin resistance - Homo sapiens (human);HIF-1 signaling pathway - Homo sapiens (human);Longevity regulating pathway - multiple species - Homo sapiens (human);Acute myeloid leukemia - Homo sapiens (human);Breast cancer - Homo sapiens (human);ErbB signaling pathway - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Longevity regulating pathway - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Colorectal cancer - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);IL-5 Signaling Pathway;AMP-activated Protein Kinase (AMPK) Signaling;Follicle Stimulating Hormone (FSH) signaling pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Cytoplasmic Ribosomal Proteins;Insulin Signaling;IL-2 Signaling Pathway;Disease;Signal Transduction;AKT phosphorylates targets in the nucleus;IL-7 signaling;PIP3 activates AKT signaling;JAK STAT pathway and regulation;EPO signaling;Constitutive Signaling by AKT1 E17K in Cancer;PI3K/AKT Signaling in Cancer;VEGF;Intracellular signaling by second messengers;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.286
Intolerance Scores
- loftool
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 32.15
Haploinsufficiency Scores
- pHI
- 0.240
- hipred
- Y
- hipred_score
- 0.512
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.905
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Rps6kb2
- Phenotype
- neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- translation;protein phosphorylation;signal transduction;intracellular signal transduction;protein kinase B signaling;positive regulation of translational initiation
- Cellular component
- nucleus;nucleoplasm;cytoplasm
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;ribosomal protein S6 kinase activity;ATP binding;peptide binding